Assenagon Asset Management S.A.
Position in CTMX — CytomX Therapeutics, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in CTMX
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$1,365,648
-$345,965 QoQ
Shares Held
364,173
0.0% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 178 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. CTMX ranks #44 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in CTMX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,365,648 | 364,173 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $1,711,613 | 364,173 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,524,884 | 592,696 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $2,328,594 | 729,967 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,634,445 | 720,020 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $452,484 | 711,454 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $617,845 | 599,850 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $1,940,118 | 1,644,168 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,510,968 | 1,238,499 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $882,189 | 404,674 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $627,244 | 404,674 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $549,438 | 425,921 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,149,015 | 668,032 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,008,728 | 668,032 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,463,840 | 914,900 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $1,544,818 | 1,065,392 | Shares | Sole | 2022-10-27 | |
| 2021-09-30 | $141,369 | 27,774 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $3,120,772 | 493,013 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,578,009 | 204,141 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,432,897 | 218,763 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $1,149,625 | 172,876 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $2,113,321 | 253,700 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||